VALIANT LABORATORIES
|
VALIANT LABORATORIES Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Profit Before Tax | ₹-1.51 Cr | ₹-0.77 Cr | ₹38 Cr |
| Adjustment | ₹4.29 Cr | ₹2.04 Cr | ₹1.56 Cr |
| Changes In working Capital | ₹-3.93 Cr | ₹-0.37 Cr | ₹25 Cr |
| Cash Flow after changes in Working Capital | ₹-1.15 Cr | ₹0.90 Cr | ₹65 Cr |
| Cash Flow from Operating Activities | ₹1.31 Cr | ₹1.89 Cr | ₹56 Cr |
| Cash Flow from Investing Activities | ₹-53 Cr | ₹-144 Cr | ₹-55 Cr |
| Cash Flow from Financing Activities | ₹45 Cr | ₹152 Cr | ₹-0.93 Cr |
| Net Cash Inflow / Outflow | ₹-6.80 Cr | ₹10 Cr | ₹-0.05 Cr |
| Opening Cash & Cash Equivalents | ₹12 Cr | ₹1.26 Cr | ₹1.31 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - |
| Closing Cash & Cash Equivalent | ₹4.92 Cr | ₹12 Cr | ₹1.26 Cr |
Compare Cashflow Statement of peers of VALIANT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VALIANT LABORATORIES | ₹678.5 Cr | 2.5% | 22.3% | 46.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,120.0 Cr | -3.2% | -5.4% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,390.0 Cr | 0.7% | 3.2% | 61.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,740.0 Cr | -2.8% | -3% | 32.6% | Stock Analytics | |
| CIPLA | ₹108,497.0 Cr | -2.9% | -3.3% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,925.0 Cr | -3.3% | 4.7% | -2.2% | Stock Analytics | |
VALIANT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VALIANT LABORATORIES | 2.5% |
22.3% |
46.1% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses